TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from OptiBiotix Health ( (GB:OPTI) ) is now available.
OptiBiotix Health plc announced that David Blain, a Director of the company, purchased 84,053 ordinary shares at 11.75 pence each, increasing his stake to 0.08% of the issued ordinary shares. This transaction, disclosed under UK Market Abuse Regulation, highlights insider confidence in the company’s strategic direction and potential growth, possibly affecting investor sentiment positively.
More about OptiBiotix Health
OptiBiotix Health plc is a life sciences company focused on developing products that modify the human microbiome to manage diseases and promote wellness. The company, founded in 2012, collaborates with international food and healthcare companies to integrate its microbiome modulators into various food and drink products. OptiBiotix also develops consumer supplements targeting obesity, cardiovascular health, and diabetes.
Average Trading Volume: 219,133
Technical Sentiment Signal: Sell
Current Market Cap: £11.1M
For an in-depth examination of OPTI stock, go to TipRanks’ Overview page.